Why the study?
Does transgenic overexpression of human lipoprotein lipase alter VLDL metabolism and perinatal survival in mice?
Population
Transgenic mice expressing human lipoprotein lipase (LPL) driven by the mouse metallothionein I promoter
Comparison
Transgenic overexpression of human lipoprotein… vs Control animals (non-transgenic mice)
Design
Preclinical
Authors
Loading...
May inform LPL-targeted triglyceride therapies; leaves open perinatal safety and human translation from mouse models.
Does transgenic overexpression of human lipoprotein lipase alter VLDL metabolism and perinatal survival in mice?
Overexpression of human LPL in transgenic mice significantly reduces plasma VLDL and abolishes diet-induced hypertriglyceridemia, though it causes high perinatal mortality that is preventable by maternal high-fat diet.
Zsigmond et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: